Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4-1BB agonist for liver cancer treatment.
Wu Q, Pan C, Zhou Y, Wang S, Xie L, Zhou W, Ding L, Chen T, Qian J, Su R, Gao X, Mei Z, Qiao Y, Yin S, Wu Y, Wang J, Zhou L, Zheng S.
Wu Q, et al. Among authors: wu y.
Hepatology. 2023 Nov 1;78(5):1402-1417. doi: 10.1097/HEP.0000000000000320. Epub 2023 Feb 23.
Hepatology. 2023.
PMID: 36811396